United States Biotechnology & Medical Research

Solid Biosciences Inc (SLDB)

Track

Track

Solid Biosciences Inc. experienced multiple insider transactions on February 18, 2026, involving various executives and directors. These activities included both direct sales and proposed divestments of equity. Earlier, on February 4, 2026, additional selling occurred. Given that these events transpired over three months ago, no assessment regarding current market valuation or performance is provided.
Ticker: SLDB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Solid Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
135.68
Quantity 87,786 -33.1%
Value US$4,563,907
2.7
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
171.65
Quantity 78,967
Value US$1,830,384
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
162.62
Quantity 75,084
Value US$2,996,901
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.82
Quantity 4,134 -5.3%
Value US$24,074
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 4,134
Value US$24,074
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
5.82
Quantity 2,658 -8.8%
Value US$15,478
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 3,616
Value US$21,057
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
5.82
Quantity 3,616 -4.7%
Value US$21,057
2.5
Ganot Ilan Director Non-Executive Director
Transaction date
Proposed sale
Price
5.92
Quantity 2,658
Value US$15,748
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.82
Quantity 7,469 -6.6%
Value US$43,494
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 7,469
Value US$43,494
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 5,404
Value US$31,469
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
5.82
Quantity 5,404 -5.2%
Value US$31,469
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
6.44
Quantity 14,783 -13.6%
Value US$95,231
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
6.44
Quantity 18,894 -16.2%
Value US$121,713
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
6.44
Quantity 7,205 -22.2%
Value US$46,414
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
6.44
Quantity 48,913 -18.1%
Value US$315,093
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
6.44
Quantity 10,905 -13.6%
Value US$70,249
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
6.44
Quantity 12,348 -14.9%
Value US$79,545
2.7
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
6.44
Quantity 12,616 -13.0%
Value US$81,271
2.7
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 12,616
Value US$81,268
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 12,348
Value US$79,541
2.5
Ganot Ilan Director Non-Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 7,205
Value US$46,412
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 14,783
Value US$95,227
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 10,905
Value US$70,247
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 48,913
Value US$315,080
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 18,894
Value US$121,708
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,535
Value US$170,803
2.7
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 28,335
Value US$182,390
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,837
Value US$172,747
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 80,258
Value US$516,613
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 37,771
Value US$243,128
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,250
Value US$168,969
2.7
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
6.44
Quantity 28,335 -22.7%
Value US$182,390
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
6.44
Quantity 37,771 -24.4%
Value US$243,128
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
6.44
Quantity 80,258 -22.9%
Value US$516,613
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
6.44
Quantity 26,535 -24.3%
Value US$170,803
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
6.44
Quantity 26,250 -24.7%
Value US$168,969
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
6.44
Quantity 26,837 -19.8%
Value US$172,747
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
6.59
Quantity 191 -1.1%
Value US$1,259
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
5.27
Quantity 5,704
Value US$30,060
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Planned sale
Price
5.27
Quantity 5,704 -11.0%
Value US$30,060
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
5.43
Quantity 1,053 -5.7%
Value US$5,718
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.11
Quantity 4,932 -13.0%
Value US$25,203
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.11
Quantity 4,483 -14.4%
Value US$22,908
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
5.11
Quantity 2,701 -9.2%
Value US$13,802
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
5.11
Quantity 10,808 -11.7%
Value US$55,229
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.11
Quantity 10,808
Value US$55,229
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
4.12
Quantity 3,278 -3.3%
Value US$13,505
2.7
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
5.96
Quantity 2,895 -7.9%
Value US$17,254
3.6
Kahn Clare Non-Executive Director
Transaction date
Purchase
Price
5.34
Quantity 1,860 +169.1%
Value US$9,924
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.03
Quantity 5,000,000 +73.2%
Value US$20,150,000
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
3.96
Quantity 3,164 -8.9%
Value US$12,529
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
3.96
Quantity 5,561 -18.3%
Value US$22,022
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
3.96
Quantity 1,711 -10.3%
Value US$6,776
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
3.96
Quantity 3,079 -13.8%
Value US$12,193
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
3.96
Quantity 11,365 -15.8%
Value US$45,005
2.7
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
3.96
Quantity 3,256 -12.5%
Value US$12,894
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
3.96
Quantity 2,688 -12.8%
Value US$10,644
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 5,561
Value US$22,022
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 2,688
Value US$10,644
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 3,164
Value US$12,529
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.96
Quantity 11,365
Value US$45,005
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 3,079
Value US$12,193
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
3.11
Quantity 144 -1.2%
Value US$448
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Planned sale
Price
3.89
Quantity 4,073 -14.1%
Value US$15,849
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
4.31
Quantity 1,056 -8.4%
Value US$4,551
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.60
Quantity 11,114
Value US$62,236
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
5.60
Quantity 5,072
Value US$28,396
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.60
Quantity 4,610 -24.5%
Value US$25,822
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
5.60
Quantity 11,114 -22.4%
Value US$62,236
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.60
Quantity 5,072 -24.5%
Value US$28,396
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
5.60
Quantity 2,777 -18.6%
Value US$15,551
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-18 2026-02-18 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
87,786 -33.1%
135.68
US$4,563,907 		87,786 -33.1% 135.68 US$4,563,907
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Brooks Gabriel

Officer

Officer
78,967
171.65
US$1,830,384 		78,967 171.65 US$1,830,384
2026-02-18 2026-02-18 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
75,084
162.62
US$2,996,901 		75,084 162.62 US$2,996,901
2026-02-18 2026-02-18 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,134 -5.3%
5.82
US$24,074 		4,134 -5.3% 5.82 US$24,074
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
4,134
5.82
US$24,074 		4,134 5.82 US$24,074
2026-02-18 2026-02-18 S Sale
2.5
Ganot Ilan
Non-Executive Director
2,658 -8.8%
5.82
US$15,478 		2,658 -8.8% 5.82 US$15,478
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
3,616
5.82
US$21,057 		3,616 5.82 US$21,057
2026-02-18 2026-02-18 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
3,616 -4.7%
5.82
US$21,057 		3,616 -4.7% 5.82 US$21,057
2026-02-18 2026-02-18 PrS Proposed sale
2.5
Ganot Ilan

Director

Non-Executive Director
2,658
5.92
US$15,748 		2,658 5.92 US$15,748
2026-02-18 2026-02-18 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
7,469 -6.6%
5.82
US$43,494 		7,469 -6.6% 5.82 US$43,494
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Howton David T

Officer

Officer
7,469
5.82
US$43,494 		7,469 5.82 US$43,494
2026-02-18 2026-02-18 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
5,404
5.82
US$31,469 		5,404 5.82 US$31,469
2026-02-18 2026-02-18 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
5,404 -5.2%
5.82
US$31,469 		5,404 -5.2% 5.82 US$31,469
2026-02-06 2026-02-04 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
14,783 -13.6%
6.44
US$95,231 		14,783 -13.6% 6.44 US$95,231
2026-02-06 2026-02-04 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
18,894 -16.2%
6.44
US$121,713 		18,894 -16.2% 6.44 US$121,713
2026-02-06 2026-02-04 S Sale
2.5
Ganot Ilan
Non-Executive Director
7,205 -22.2%
6.44
US$46,414 		7,205 -22.2% 6.44 US$46,414
2026-02-06 2026-02-04 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
48,913 -18.1%
6.44
US$315,093 		48,913 -18.1% 6.44 US$315,093
2026-02-06 2026-02-04 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
10,905 -13.6%
6.44
US$70,249 		10,905 -13.6% 6.44 US$70,249
2026-02-06 2026-02-04 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
12,348 -14.9%
6.44
US$79,545 		12,348 -14.9% 6.44 US$79,545
2026-02-06 2026-02-04 S Sale
2.7
Brooks Gabriel

Chief Medical Officer

Officer
12,616 -13.0%
6.44
US$81,271 		12,616 -13.0% 6.44 US$81,271
2026-02-04 2026-02-04 PrS Proposed sale
2.7
Brooks Gabriel

Officer

Officer
12,616
6.44
US$81,268 		12,616 6.44 US$81,268
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
12,348
6.44
US$79,541 		12,348 6.44 US$79,541
2026-02-04 2026-02-04 PrS Proposed sale
2.5
Ganot Ilan

Director

Non-Executive Director
7,205
6.44
US$46,412 		7,205 6.44 US$46,412
2026-02-04 2026-02-04 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
14,783
6.44
US$95,227 		14,783 6.44 US$95,227
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
10,905
6.44
US$70,247 		10,905 6.44 US$70,247
2026-02-04 2026-02-04 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
48,913
6.44
US$315,080 		48,913 6.44 US$315,080
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Howton David T

Officer

Officer
18,894
6.44
US$121,708 		18,894 6.44 US$121,708
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
26,535
6.44
US$170,803 		26,535 6.44 US$170,803
2026-02-02 2026-02-02 PrS Proposed sale
2.7
Brooks Gabriel

Officer

Officer
28,335
6.44
US$182,390 		28,335 6.44 US$182,390
2026-02-02 2026-02-02 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
26,837
6.44
US$172,747 		26,837 6.44 US$172,747
2026-02-02 2026-02-02 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
80,258
6.44
US$516,613 		80,258 6.44 US$516,613
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Howton David T

Officer

Officer
37,771
6.44
US$243,128 		37,771 6.44 US$243,128
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
26,250
6.44
US$168,969 		26,250 6.44 US$168,969
2026-02-02 2026-02-02 S Sale
2.7
Brooks Gabriel

Chief Medical Officer

Officer
28,335 -22.7%
6.44
US$182,390 		28,335 -22.7% 6.44 US$182,390
2026-02-02 2026-02-02 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
37,771 -24.4%
6.44
US$243,128 		37,771 -24.4% 6.44 US$243,128
2026-02-02 2026-02-02 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
80,258 -22.9%
6.44
US$516,613 		80,258 -22.9% 6.44 US$516,613
2026-02-02 2026-02-02 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
26,535 -24.3%
6.44
US$170,803 		26,535 -24.3% 6.44 US$170,803
2026-02-02 2026-02-02 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
26,250 -24.7%
6.44
US$168,969 		26,250 -24.7% 6.44 US$168,969
2026-02-02 2026-02-02 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
26,837 -19.8%
6.44
US$172,747 		26,837 -19.8% 6.44 US$172,747
2026-01-30 2026-01-28 S Sale
2.5
Ganot Ilan
Non-Executive Director
191 -1.1%
6.59
US$1,259 		191 -1.1% 6.59 US$1,259
2026-01-13 2026-01-13 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
5,704
5.27
US$30,060 		5,704 5.27 US$30,060
2026-01-13 2026-01-13 PlS Planned sale
2.1
Tan Kevin

CFO & Treasurer

Officer
5,704 -11.0%
5.27
US$30,060 		5,704 -11.0% 5.27 US$30,060
2026-01-06 2026-01-05 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,053 -5.7%
5.43
US$5,718 		1,053 -5.7% 5.43 US$5,718
2025-12-04 2025-12-03 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
4,932 -13.0%
5.11
US$25,203 		4,932 -13.0% 5.11 US$25,203
2025-12-04 2025-12-03 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,483 -14.4%
5.11
US$22,908 		4,483 -14.4% 5.11 US$22,908
2025-12-04 2025-12-03 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
2,701 -9.2%
5.11
US$13,802 		2,701 -9.2% 5.11 US$13,802
2025-12-04 2025-12-03 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
10,808 -11.7%
5.11
US$55,229 		10,808 -11.7% 5.11 US$55,229
2025-12-03 2025-12-03 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
10,808
5.11
US$55,229 		10,808 5.11 US$55,229
2025-11-13 2025-11-10 S Sale
2.5
Ganot Ilan
Non-Executive Director
3,278 -3.3%
4.12
US$13,505 		3,278 -3.3% 4.12 US$13,505
2025-10-21 2025-10-20 S Sale
2.7
Brooks Gabriel

Chief Medical Officer

Officer
2,895 -7.9%
5.96
US$17,254 		2,895 -7.9% 5.96 US$17,254
2025-03-13 2025-03-11 B Purchase
3.6
Kahn Clare
Non-Executive Director
1,860 +169.1%
5.34
US$9,924 		1,860 +169.1% 5.34 US$9,924
2025-02-21 2025-02-19 B Purchase
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
1,000,000 +24.8%
4.03
US$4,030,000 		1,000,000 +24.8% 4.03 US$4,030,000
2025-02-21 2025-02-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
5,000,000 +73.2%
4.03
US$20,150,000 		5,000,000 +73.2% 4.03 US$20,150,000
2025-02-19 2025-02-18 B Purchase
0.5
Adage Capital Management, L.P.
Large shareholder
252,545 +6.3%
7.56
US$1,909,240 		252,545 +6.3% 7.56 US$1,909,240
2025-02-18 2025-02-14 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
3,164 -8.9%
3.96
US$12,529 		3,164 -8.9% 3.96 US$12,529
2025-02-18 2025-02-14 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
5,561 -18.3%
3.96
US$22,022 		5,561 -18.3% 3.96 US$22,022
2025-02-18 2025-02-14 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,711 -10.3%
3.96
US$6,776 		1,711 -10.3% 3.96 US$6,776
2025-02-18 2025-02-14 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
3,079 -13.8%
3.96
US$12,193 		3,079 -13.8% 3.96 US$12,193
2025-02-18 2025-02-14 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
11,365 -15.8%
3.96
US$45,005 		11,365 -15.8% 3.96 US$45,005
2025-02-18 2025-02-14 S Sale
2.7
Brooks Gabriel

Chief Medical Officer

Officer
3,256 -12.5%
3.96
US$12,894 		3,256 -12.5% 3.96 US$12,894
2025-02-18 2025-02-14 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
2,688 -12.8%
3.96
US$10,644 		2,688 -12.8% 3.96 US$10,644
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Howton David T

Officer

Officer
5,561
3.96
US$22,022 		5,561 3.96 US$22,022
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
2,688
3.96
US$10,644 		2,688 3.96 US$10,644
2025-02-14 2025-02-14 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
3,164
3.96
US$12,529 		3,164 3.96 US$12,529
2025-02-14 2025-02-14 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
11,365
3.96
US$45,005 		11,365 3.96 US$45,005
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
3,079
3.96
US$12,193 		3,079 3.96 US$12,193
2025-01-29 2025-01-28 S Sale
2.5
Ganot Ilan
Non-Executive Director
144 -1.2%
3.11
US$448 		144 -1.2% 3.11 US$448
2025-01-13 2025-01-10 PlS Planned sale
2.1
Tan Kevin

CFO & Treasurer

Officer
4,073 -14.1%
3.89
US$15,849 		4,073 -14.1% 3.89 US$15,849
2025-01-07 2025-01-06 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,056 -8.4%
4.31
US$4,551 		1,056 -8.4% 4.31 US$4,551
2024-12-05 2024-12-03 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
11,114
5.60
US$62,236 		11,114 5.60 US$62,236
2024-12-04 2024-12-03 PrS Proposed sale
2.4
Howton David T

Officer

Officer
5,072
5.60
US$28,396 		5,072 5.60 US$28,396
2024-12-04 2024-12-03 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,610 -24.5%
5.60
US$25,822 		4,610 -24.5% 5.60 US$25,822
2024-12-04 2024-12-03 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
11,114 -22.4%
5.60
US$62,236 		11,114 -22.4% 5.60 US$62,236
2024-12-04 2024-12-03 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
5,072 -24.5%
5.60
US$28,396 		5,072 -24.5% 5.60 US$28,396
2024-12-04 2024-12-03 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
2,777 -18.6%
5.60
US$15,551 		2,777 -18.6% 5.60 US$15,551
Explore more

More insider trading research around Solid Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America